Investor

Investors

Investor Overview

Sanovas is disrupting and expanding multi-billion dollar diagnostic and therapeutic categories by improving quality and cost-effective access to advanced minimally invasive technologies worldwide. To understand how we are providing safe, easy, affordable access and visualization in small anatomies to enable advanced diagnostic and therapeutic interventions, click here for a video presentation. This overview is not a solicitation for investment.

Detailed Investor Information

If you would like to receive more detailed information regarding Sanovas investment opportunities, please click on the link below. You will be directed to complete information that complies with the Securities and Exchange Commission's (SEC) rule 506(d) requirements. You will also be asked to complete a non-disclosure agreement (NDA).

Read and Sign the Sanovas NDA for Investors

FDA REGULATORY DISCLOSURE: Sanovas Inc. is an emerging technology company.
These products are investigational medical devices that have not been approved or cleared for use in the United States.